Individual Health Factors and Risk Stratification in GLP-1 Safety Beyond drug interactions, personal medical historypancreatitis risk, thyroid cancer family history, kidney disease, or gallbladder conditionsshapes GLP-1 suitability
Now we're starting to use the GLP-1s, and we're seeing those antibody levels come down
Both rapid-acting insulin analogs (insulin lispro, insulin aspart) and long-acting basal insulins (insulin detemir, insulin glargine) have been studied extensively in pregnant women and are not associated with increased birth defect risks
Ozempic is approved for type 2 diabetes management, whilst Wegovy is specifically licensed for weight management in adults with obesity or overweight with comorbidities
Schwickart et al Bioanalysis (2014) 6(14), 19391951 Antibody array analysis of labelled proteomes: how should we control specificity